Keywords: 2,5-DXP; 2,5-diketopiperazine; ACC; adenoid cystic carcinomas; BBR; berberine; BET; bromodomain and extraterminal; CA; chebulagic acid; CPT; camptothecin; EMT; epithelial-mesenchymal transition; GSK3; glycogen synthase kinase 3-; HCC; hepatocellular carci
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Genomic convergence; PRAME; ROBO1; Axon guidance; Human speech/language;
Keywords: 4-HPR; N-(4-hydroxyphenyl)retinamide; 5â²-UTR; 5â²-untranslated region; 9-cis-RA; 9-cis retinoic acid; 9cUAB30; (2E,4E,6Z,8E)-8-(3â²,4â²-dihydro-1â²(2'H)-naphthalen-1â²-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid; Acitretin; (2E,4E,6E,8E)-9-(4-met
Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?
Keywords: Breast cancer; Tumor antigens; NY-ESO-1; MAGE-A3; PRAME; WT1; Vaccine; Immunotherapy;
Original ArticleTumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells
Keywords: PRAME; MZF1; DNA methylation; Gene expression; Melanoma; PRAME; preferentially expressed antigen in melanoma; MZF1; myeloid zinc finger 1; 5-azaC; 5-aza-2â²-deoxycitidine; siRNA; small interfering RNA; RT-qPCR; reverse transcription-quantitative polymera
Original contributionCancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1
Keywords: Cancer-testis antigen; Sarcoma; NY-ESO-1; PRAME; MAGE;
Hematologic neoplasms: Dendritic cells vaccines in motion
Keywords: DCs; dendritic cells; TAA; tumor-associated antigens; APC; antigen presenting cells; mDCs; myeloid dendritic cells; pDCs; plasmacytoid dendritic cells; HLA; human leukocyte antigen; Ag Antigens; abs antibodies; PBMCs; peripheral blood mononuclear cells; G
PRAME is critical for breast cancer growth and metastasis
Keywords: EMT; epithelial-mesenchymal transition; TGF-β; transforming growth factor-β; EGF; epidermal growth factor; PRAME; melanoma antigen preferentially expressed in tumors; E-cadherin; epithelial cadherin; PRAME; E-cadherin; Breast cancer;
The in vitro generation of multi-tumor antigen-specific cytotoxic T cell clones: Candidates for leukemia adoptive immunotherapy following allogeneic stem cell transplantation
Keywords: AML; acute myeloid leukemia; ASCT; allogeneic stem cell transplantation; CFSE; carboxyfluorescein diacetate succinimidyl ester; FBS; fetal bovine serum; GVT; Graft-versus-tumor; GVHD; Graft-versus-host disease; GVL; graft-versus-leukemia; HAT; hypoxanthin
The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus
Keywords: CLL; 22q11; Immunoglobulin lambda light chain locus; IGL; IGLV; PRAME
Expression and prognostic relevance of PRAME in primary osteosarcoma
Keywords: PRAME; Preferentially expressed antigen of melanoma; Osteosarcoma; Prognosis; siRNA; Proliferation;
Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells
Keywords: PRAME; siRNA; Acute leukemia; Cell cycle; Apoptosis; Differentiation
Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia
Keywords: RT-PCR; reverse transcriptase polymerase chain reaction; RNA; ribonucleic acid; cDNA; complementary deoxyribonucleic acid; ELISA; enzyme-linked immunosorbent assay; Cancer-testis antigens; Tumor immunology; PRAME; Imatinib; Chronic myeloid leukemia;
Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease
Keywords: WT1; PRAME; Acute myeloid leukemia; Minimal residual disease; Real-time quantitative PCR
PRAME expression in hairy cell leukemia
Keywords: Hairy cell leukemia; Real-time PCR; Chronic lymphocytic leukemia; PRAME; TaqMan; Minimal residual disease
Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia
Keywords: PRAME; Acute leukemia; Children; Molecular markers
PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature
Keywords: Chronic leukemia; PRAME; Minimal residual disease; Immunotherapy
Epigenetic regulation of PRAME gene in chronic myeloid leukemia
Keywords: PRAME; Hypomethylation; CML
PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma
Keywords: PRAME; CLL; Mantle cell lymphoma; Quantitative flow cytometry
Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors
Keywords: Microarray; Expression array; Ovarian cancer; Gene expression; Survival; Tumour marker; TACC1; MUC5B; PRAME; Prognostic factors